Ansa Biotechnologies
PrivateLast Round
Series B
Oct 1, 2025
Total Funding Raised
$132.59M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ansa Biotechnologies operates in Healthcare & Life Sciences and is based in Emeryville, California. Its latest recorded funding round was a Series B round in October 2025.
Ansa Biotechnologies is a biotechnology company that provides enzymatic DNA synthesis services to accelerate biological research and synthetic biology innovation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ansa Biotechnologies Comparables
Compare Ansa Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elegen | 89% | |
| Ribbon Bio | 86% | |
| Camena Bioscience | 85% |
For institutional investors. Book with your work email.
Ansa Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 1, 2025 | ||||
| Series A | Apr 11, 2022 | ||||
| Grant | Apr 15, 2021 | ||||
| Seed | Sep 14, 2020 | ||||
| Pre Seed | Dec 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ansa Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Seed, Series A |
| RA Capital Management | Series A |
| Fall Line Capital | Series B |
| Codon Capital | Series A |
| PEAK6 Strategic Capital | Series A |
| Altitude Life Science Ventures | Series A, Series B |
| Carbon Silicon Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 58% MoM.
- May 4, 2026
Will present at SynBioBeta 2026 conference in San Jose, CA.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientAug 24, 2026
Ansa Biotechnologies, Inc. signs Axio BioPharma Inc. as a new client after Axio BioPharma Inc. selects Ansa Biotechnologies, Inc. as its preferred gene synthesis provider to reduce schedule risk and improve delivery predictability in Wisconsin on Aug 24th '26.
For institutional investors. Book with your work email.
Ansa Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ansa Biotechnologies's valuation, stock price, and market status.
Is Ansa Biotechnologies a public or private company?
Ansa Biotechnologies is a private company.
What is the current stock price of Ansa Biotechnologies?
Ansa Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Ansa Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ansa Biotechnologies worth (valuation)?
Valuation information for Ansa Biotechnologies is not publicly available.
Can I buy Ansa Biotechnologies stock?
Ansa Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ansa Biotechnologies's last funding round?
Ansa Biotechnologies's most recent funding round was Series B on October 1, 2025.
Who are the main investors in Ansa Biotechnologies?
Key investors in Ansa Biotechnologies include Horizons Ventures, Cerberus Ventures, Northpond Ventures, Northpond Ventures, Fifty Years.
Will Ansa Biotechnologies IPO soon?
No public IPO plans have been announced for Ansa Biotechnologies.
How can I track Ansa Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Ansa Biotechnologies's shares on secondary markets.